Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cytotherapy|May 31, 2024
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumorsAnne Miller, Rachel Daum, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Bone Marrow Transplantation|February 2, 2022
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphomaBrian D Friend, Ibrahim N Muhsen, Shreeya Patel, et al.
The New England Journal of Medicine|November 4, 2011
Inducible apoptosis as a safety switch for adoptive cell therapyAntonio Di Stasi, Siok-Keen Tey, Gianpietro Dotti, et al.
Blood|April 23, 2014
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgeneXiaoou Zhou, Antonio Di Stasi, Siok-Keen Tey, et al.
Blood|February 8, 2022
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALLSwati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, et al.
Blood Advances|December 1, 2022
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survivalCaridad Martinez, Paibel Aguayo-Hiraldo, Natalia Chaimowitz, et al.
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Journal of Human Immunity|January 29, 2026
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC studyVirdette L Brumm, Sharon A Kidd, Brent R Logan, et al.
Journal of Human Immunity|October 27, 2025
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridgingEmilie Pauline Buddingh, Mary Slatter, Juan Carlos Aldave Becerra, et al.
Pageof 4